We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+7.29%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$22.1B
AUM Growth
+$302M
Cap. Flow
-$1.3B
Cap. Flow %
-5.9%
Top 10 Hldgs %
11.41%
Holding
3,562
New
1,146
Increased
641
Reduced
606
Closed
971

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$148M
2
NFLX icon
Netflix
NFLX
+$119M
3
ABNB icon
Airbnb
ABNB
+$111M
4
XYZ
Block Inc
XYZ
+$89.5M
5
DHR icon
Danaher
DHR
+$88.6M

Top Sells

Rank Stock Value
1
CRL icon
Charles River Laboratories
CRL
+$212M
2
BABA icon
Alibaba
BABA
+$172M
3
ZTS icon
Zoetis
ZTS
+$133M
4
TRU icon
TransUnion
TRU
+$124M
5
BIDU icon
Baidu
BIDU
+$111M

Sector Composition

Rank Sector Weight
1 Healthcare 20.88%
2 Financials 13.4%
3 Consumer Discretionary 12.06%
4 Technology 11.2%
5 Communication Services 8.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AXSM icon
2626
Axsome Therapeutics
AXSM
$11.7B
-23,374
Closed -$1.32M
AZO icon
2627
AutoZone
AZO
$51.3B
-6,397
Closed -$8.98M
BAK icon
2628
Braskem
BAK
$901M
-127,284
Closed -$1.81M
BANC icon
2629
Banc of California
BANC
$2.87B
-11,625
Closed -$210K
BAP icon
2630
Credicorp
BAP
$30.5B
-160,821
Closed -$22M
BARK icon
2631
BARK
BARK
$77.9M
-1,648
Closed -$366K
BBCP icon
2632
Concrete Pumping Holdings
BBCP
$491M
-92,466
Closed -$685K
BBIO icon
2633
BridgeBio Pharma
BBIO
$16.4B
-75,995
Closed -$4.68M
BCO icon
2634
Brink's
BCO
$5.01B
-10,563
Closed -$837K
BCRX icon
2635
BioCryst Pharmaceuticals
BCRX
$2.42B
-182,905
Closed -$1.86M
BDTX icon
2636
Black Diamond Therapeutics
BDTX
$95.1M
-140,232
Closed -$3.4M
BDX icon
2637
Becton Dickinson
BDX
$46.4B
-1,159
Closed -$275K
BFH icon
2638
Bread Financial
BFH
$4.32B
-13,253
Closed -$1.19M
BG icon
2639
Bunge Global
BG
$20.9B
-5,976
Closed -$474K
BHE icon
2640
Benchmark Electronics
BHE
$2.66B
-20,592
Closed -$637K
CMRC
2641
Commerce.com Inc Series 1
CMRC
$272M
-224,624
Closed -$13M
BNY
2642
Bank of New York Mellon
BNY
$103B
-42,125
Closed -$1.99M
BKKT icon
2643
Bakkt Inc
BKKT
$306M
-558
Closed -$181K
BKR icon
2644
Baker Hughes
BKR
$58.3B
-228,934
Closed -$4.95M
BL icon
2645
BlackLine
BL
$1.9B
-27,411
Closed -$2.97M
BLKB icon
2646
Blackbaud
BLKB
$1.94B
-5,585
Closed -$397K
BLNK icon
2647
Blink Charging
BLNK
$67.5M
-6,304
Closed -$259K
BMI icon
2648
Badger Meter
BMI
$3.87B
-2,386
Closed -$222K
BMRA icon
2649
Biomerica
BMRA
$4.91M
-20,655
Closed -$902K
BNL icon
2650
Broadstone Net Lease
BNL
$4.25B
-10,748
Closed -$197K

Similar funds

Marshall Wace's Q2 2021 Portfolio in Review

As of Q2 2021, Marshall Wace held 3,562 positions worth $22.1B, up 1.4% from $21.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Marshall Wace withdrew a net $1.3B in Q2 2021, closing 971 positions and reducing 606 holdings. Its most notable exit was Pinterest, an estimated $88.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Marshall Wace opened a new position in West Pharmaceutical worth $55.8M.

  • Marshall Wace's largest Q2 2021 buy was West Pharmaceutical: 155,316 shares worth $55.8M.
  • Marshall Wace added most to Biogen in Q2 2021, an estimated $148M increase.
  • Marshall Wace's biggest Q2 2021 reduction was Charles River Laboratories, cutting an estimated $212M.
  • Marshall Wace fully exited Pinterest in Q2 2021, selling an estimated $88.8M.
  • Marshall Wace's ten largest holdings make up 11% of its $22.1B portfolio in Q2 2021.
  • Marshall Wace opened 1,146 new positions and closed 971 in Q2 2021.
  • Marshall Wace's portfolio value rose 1.4% quarter-over-quarter to $22.1B.

Based on Marshall Wace's 13F filing for Q2 2021, filed 13 Aug 2021.